These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 16973145

  • 1. Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor.
    Sabel MS, Arora A, Su G, Chang AE.
    Cryobiology; 2006 Dec; 53(3):360-6. PubMed ID: 16973145
    [Abstract] [Full Text] [Related]

  • 2. Rate of freeze alters the immunologic response after cryoablation of breast cancer.
    Sabel MS, Su G, Griffith KA, Chang AE.
    Ann Surg Oncol; 2010 Apr; 17(4):1187-93. PubMed ID: 20033323
    [Abstract] [Full Text] [Related]

  • 3. Immunologic response to cryoablation of breast cancer.
    Sabel MS, Nehs MA, Su G, Lowler KP, Ferrara JL, Chang AE.
    Breast Cancer Res Treat; 2005 Mar; 90(1):97-104. PubMed ID: 15770533
    [Abstract] [Full Text] [Related]

  • 4. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS, Miller CH, Graham L, Parviz M, Zacur S, Patel B, Duong A, Bear HD.
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [Abstract] [Full Text] [Related]

  • 5. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer.
    Dobrzanski MJ, Reome JB, Hylind JC, Rewers-Felkins KA, Abulsamad K, Adams SL.
    Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346
    [Abstract] [Full Text] [Related]

  • 6. Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells.
    Tamai H, Watanabe S, Zheng R, Deguchi K, Cohen PA, Koski GK, Shu S.
    Clin Immunol; 2008 Apr; 127(1):66-77. PubMed ID: 18262845
    [Abstract] [Full Text] [Related]

  • 7. Bryostatin/ionomycin-activated T cells mediate regression of established tumors.
    Chin CS, Graham LJ, Hamad GG, George KR, Bear HD.
    J Surg Res; 2001 Jun 15; 98(2):108-15. PubMed ID: 11397126
    [Abstract] [Full Text] [Related]

  • 8. A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer.
    Vendrell A, Gravisaco MJ, Pasetti MF, Croci M, Colombo L, Rodríguez C, Mongini C, Waldner CI.
    Vaccine; 2011 Jan 17; 29(4):728-36. PubMed ID: 21095252
    [Abstract] [Full Text] [Related]

  • 9. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
    Dobrzanski MJ, Reome JB, Hylind JC, Rewers-Felkins KA, Abdulsamad K, Adams SL.
    Immunol Invest; 2008 Jan 17; 37(4):315-38. PubMed ID: 18569073
    [Abstract] [Full Text] [Related]

  • 10. Skewing the T-cell repertoire by combined DNA vaccination, host conditioning, and adoptive transfer.
    Jorritsma A, Bins AD, Schumacher TN, Haanen JB.
    Cancer Res; 2008 Apr 01; 68(7):2455-62. PubMed ID: 18381454
    [Abstract] [Full Text] [Related]

  • 11. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
    Kilinc MO, Gu T, Harden JL, Virtuoso LP, Egilmez NK.
    J Immunol; 2009 Apr 01; 182(7):4217-25. PubMed ID: 19299720
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of T cell localization in mammary tumors through transient inhibition of T cell myosin function.
    Ratner S, Wei WZ, Oliver J, Oliver J.
    Cell Immunol; 2005 Jan 01; 233(1):1-10. PubMed ID: 15936742
    [Abstract] [Full Text] [Related]

  • 13. Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis.
    Xiong Z, Gharagozlou S, Vengco I, Chen W, Ohlfest JR.
    Clin Cancer Res; 2008 Sep 01; 14(17):5484-93. PubMed ID: 18765540
    [Abstract] [Full Text] [Related]

  • 14. Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan.
    Mortara L, Balza E, Sassi F, Castellani P, Carnemolla B, De Lerma Barbaro A, Fossati S, Tosi G, Accolla RS, Borsi L.
    Eur J Immunol; 2007 Dec 01; 37(12):3381-92. PubMed ID: 18022863
    [Abstract] [Full Text] [Related]

  • 15. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.
    Becker C, Pohla H, Frankenberger B, Schüler T, Assenmacher M, Schendel DJ, Blankenstein T.
    Nat Med; 2001 Oct 01; 7(10):1159-62. PubMed ID: 11590442
    [Abstract] [Full Text] [Related]

  • 16. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors.
    Ben-Hur H, Kossoy G, Zandbank J, Zusman I.
    Int J Mol Med; 2002 Apr 01; 9(4):425-30. PubMed ID: 11891540
    [Abstract] [Full Text] [Related]

  • 17. T-cells for tumor therapy can be obtained from antigen-loaded sponge implants.
    Chen W, Reese VA, Cheever MA.
    Cancer Res; 1994 Feb 15; 54(4):1065-70. PubMed ID: 8313363
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M, Kudo-Saito C, Hasegawa G, Yano K, Yamamoto A, Yaguchi M, Toda M, Azuma I, Iwai T, Kawakami Y.
    Clin Cancer Res; 2006 Dec 15; 12(24):7465-75. PubMed ID: 17189420
    [Abstract] [Full Text] [Related]

  • 19. Response of T and B lymphocytes in the spleen, lymph nodes and mammary tumors in rats treated with human soluble tumor-associated antigens and commercial human albumin.
    Ben-Hur H, Kossoy G, Mehrdad H, Elhayany A, Zusman I.
    Oncol Rep; 2004 Dec 15; 12(6):1329-33. PubMed ID: 15547759
    [Abstract] [Full Text] [Related]

  • 20. Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma.
    De Giovanni C, Nicoletti G, Landuzzi L, Rossi I, Astolfi A, Ricci C, Di Carlo E, Musiani P, Forni G, Fradelizi D, Nanni P, Lollini PL.
    Gene Ther; 2001 Nov 15; 8(22):1698-704. PubMed ID: 11892837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.